Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1

Overview of attention for article published in Frontiers in immunology, June 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,519 followers.

RT @FrontImmunol: New Research: Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the ther…

10 Jun 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the ther…

10 Jun 2023

Reply Repost Favourite

New Research: Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1: Introduction The emergency use of… #immunology https

10 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.